Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cytotherapy. 2018 Mar 16;20(5):650–659. doi: 10.1016/j.jcyt.2018.02.369

Figure 2. Metformin supports UC-MSC viability.

Figure 2

UC-MSC-2 (A) and UC-MSC-4 (B) cell viability in response to metformin was evaluated through an MTS colorimetric assay after 7 days of treatment. No statistically significant differences were observed when compared to untreated controls.